Lv4
430 积分 2021-07-18 加入
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial
22天前
已完结
Aspergillosis: diagnosis and treatment
28天前
已完结
Invasive pulmonary aspergillosis real-world outcomes: Clinical features and risk factors associated with increased mortality
1个月前
已完结
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study
1个月前
已完结
[Multicenter clinical trial of itraconazole in the treatment of pulmonary aspergilloma. Pulmonary Aspergilloma Study Group]
1个月前
已关闭
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
1个月前
已完结
Aspergillus – Classification and Antifungal Susceptibilities
1个月前
已完结
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study
1个月前
已完结
Medical Writing Competency Model - Section 1: Functions, Tasks, and Activities
1个月前
已关闭
Medical Writing Competency Model - Section 1: Functions, Tasks, and Activities
1个月前
已完结
皖公网安备34019202002308
